INTRODUCTION
Influenza A virus (family Orthomyxoviridae) is an enveloped ssRNA virus that has been associated with pandemics, including the Spanish Flu of 1918 that claimed .40 million lives, the Asian Flu of 1957 that claimed .4 million lives and the 1968 Hong Kong Flu that claimed 1 million lives (Crosby, 1976; Webster et al., 1992) . Avian influenza viruses are contagious and widespread in birds, and are categorized as low pathogenicity avian influenza or highly pathogenic avian influenza (HPAI) viruses (Bragstad et al., 2005; Cumming et al., 2011; Williams et al., 2011) . HPAI viruses can cause mortality in 90-100 % of flocks and this virus has the ability to spread rapidly amongst flocks. HPAI infection in humans can lead to various clinical outcomes that range from mild infections to severe respiratory illness and death. Complications in severe cases included acute respiratory distress syndrome, leukopenia, lymphopenia, haemophagocytosis and multi-organ dysfunction.
Microarray analysis offers a unique opportunity to study virus-host interactions at a global level and can be used as a tool to delineate molecular mechanisms of tissue responses in animals infected with influenza virus. Moreover, these technologies may help reveal novel insights into events inside infected cells, and offer the possibility of identifying new approaches to diagnostics (de Planell-Saguer & Rodicio, 2011) and antiviral therapeutics (Neuman de Vegvar & Robinson, 2004; Saxena et al., 2010) . Subsequent changes in normal functions and protein expression profiles in response to a viral infection may be reflected in the increased or decreased mRNA expression profile; however, it should be noted that a viral response against the host could lead to the degradation or inhibition of the function of the protein target by alternative mechanisms that may not be visible at the mRNA level. Commercial gene expression technologies allow for the characterization of many transcripts from a single tissue sample; which in turn can be used to analyse the levels of mRNA transcripts in normal and diseased tissue. Analysing gene expression profiles can lead to the development of prophylactic/therapeutic treatments that target specific molecular pathways or genes that may result in the amelioration of the disease state.
MicroRNAs (miRNAs) are non-coding RNAs of 20-22 nt that regulate gene expression by regulating mRNA transcripts, which may result in protein-encoding gene alteration (Felekkis et al., 2010) . These miRNAs can also be used as indicators of disease and host-pathogen interactions (Felekkis et al., 2010; Mallick et al., 2009) . The general characteristics and/or patterns associated with various miRNAs that may be shared by a variety of different influenza viruses can be identified using microarray analyses (Li et al., 2010; Loveday et al., 2012; Rogers et al., 2012; Song et al., 2010) . Based on these patterns, the viral pathogenicity of an unknown influenza virus may be predicted without time-consuming epidemiological, molecular, biological or animal studies. Thus, the overall aim of this project was to determine specific patterns in the changes of the miRNA profiles at various time points relative to challenge that may be associated with pathogenicity in mice infected with various influenza viruses. Specific gene and protein expression/production patterns may allow for the prediction of the disease outcome. Therefore, this project may provide an example of miRNA expression profiles utilized as a 'diagnostic' tool for identifying a common fingerprint of viral pathogenicity associated with seasonal H1N1 (A/Texas/36/91), swine H1N1 (A/California/04/09) and highly pathogenic H5N1 (A/ Vietnam/1203/04).
METHODS
Animal studies. All virus work was conducted under biosafety level 3 or animal biosafety level 3 (ABSL-3) conditions. Female BALB/c mice (Mus musculus), 5-6 weeks of age at the time ordered, were used (127 mice) and were purchased from Charles River Laboratories. The mice were quarantined for at least 3 days after arrival prior to initiation of the study. For identification purposes, mice were tattooed on the tail with a unique number/identifier. Mice were randomized into groups prior to challenge (by number). The animals were housed in groups, and provided potable water and feed ad libitum. All study procedures were in accordance with the guidelines approved by the Institutional Animal Care and Use Committee.
Influenza virus challenge. Influenza challenges were performed as described previously (Rogers et al., 2012) . Briefly, the A/Vietnam/ 1203/04 (H5N1) and A/California/04/09 (H1N1) viruses were propagated in the alloantoic cavity of 10-day-old hen eggs at 37 uC and the viral stock was diluted in PBS to 5610 4 TCID 50 ml 21 . The A/ Texas/36/91 (H1N1) (NR-3223) virus stock was purchased through the BEI Research Resources Repository of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (Manassas, VA, USA). Animals were challenged via the intranasal route in a total volume of 50 ml, corresponding to 5610 4 TCID 50 of virus. Control groups received allantoic fluid diluted in PBS similar to the virus stock and administered intranasally in a 50 ml volume. All mice were placed in filtered caging by group following challenge. All experiments were conducted according to protocols reviewed and approved by the Battelle Biosafety Committee and the Institutional Animal Care and Use Committee of Battelle, which adhere to the National Institutes of Health guidelines for the care and use of laboratory animals. Influenza-infected animals were housed in an ABSL-3 enhanced facility.
Sample collection and RNA isolation. At 6, 12, 24, 72 and 96 h post-challenge, animals were anaesthetized and terminally bled. Blood collection took place under ketamine/xylazine anaesthesia (60-100/ 10-12 mg kg 21 ). Briefly, prior to challenge (baseline) and at 6, 12, 24, 72 and 96 h following intranasal inoculation, six mice from each group [three groups of animals challenged with each of the influenza viruses and one mock-challenged group (a total of four groups; 120 mice in total)] underwent a terminal bleed via heart stick. For the baseline samples, seven animals were also used for analyses to establish baseline miRNA levels. The lungs from each animal were removed and the upper half of the left lobe was placed in RNAlater for miRNA analysis. The spleen, liver, brain and a representative section of tissue from the cardiac lobe of the lung were placed in 10 % neutral buffered formalin for histopathology.
Lung samples were homogenized in QIAzol Lysis Reagent (Qiagen). The aqueous and organic phases were separated by centrifugation, after addition of chloroform to the homogenate samples. miRNA was isolated using the miRNeasy Mini kit (Qiagen). miRNA analysis. Total miRNA (100 ng) was labelled using the FlashTag biotin RNA Labelling kit (Genisphere) as described previously (Rogers et al., 2012) . Briefly, the target miRNA samples underwent labelling ligation with the biotinylated signal molecule, followed by hybridization to an Affymetrix GeneChip miRNA Array Format 400 (Affymetrix) according to the recommended protocols of the manufacturer. GeneChip Command Console software (Affymetrix) was used to process the scanned image. The miRNA QC Tool (Affymetrix) was used to perform the control analysis and data were analysed using Partek Genomics Suite (Partek). ANOVA with Tukey's HSD (honest significant difference) post hoc analysis, which included a multiple testing correction (Benjamini-Hochberg false discovery rate set at P¡0.01), was used to generate significantly changed miRNA lists.
Biological function analysis. Ingenuity Pathways Analysis 8.5 (Ingenuity Systems) was used to identify associated networks, biological functions and molecules from the knowledge base associated with miRNAs. Significant associations between datasets and the biological functions were measured as described previously (Rogers et al., 2012) . Statistical significance was calculated using Fisher's exact test.
Histopathology. Complete necropsies were performed on all mice surviving until study termination 6, 12, 24, 72 or 96 h post-infection. Tissues were sampled and fixed in 10 % neutral buffered formalin, processed to 5 mm sections for routine haematoxylin and eosin staining, and examined microscopically by a board-certified veterinary pathologist. Gross and microscopic diagnoses were entered into the PATH/TOX SYSTEM (Xybion Medical Systems) for data tabulation and analysis. Microscopic findings were graded semiquantitatively according to the following scale, with the associated numerical score used to calculate mean severity grades for each lesion by group and sex: minimal (Grade 1) represented the least detectible lesion, mild (Grade 2) represented an easily discernible lesion, moderate (Grade 3) represented a change affecting a large area of the represented tissue and marked (Grade 4) represented a lesion that approached maximal. Photomicrographs were taken using an Olympus Q-Colour 5 digital camera (Olympus America) and Image-Pro Plus 5.1 software (Media Cybernetics). Photo labels were affixed using Photoshop Elements 5.0 (Adobe).
RESULTS

Infection of mice with three distinct influenza virus strains
Female BALB/c mice, 5-6 weeks old, were divided into a single group of six mice (baseline group) and four groups of 30 mice. On study day 0, the animals were challenged with a target dose of 50 000 TCID 50 of A/Vietnam/1203/04, A/Texas/36/91 or A/California/04/09 via intranasal inoculation (total volume of 50 ml). Six animals were randomly euthanized 6, 12, 24, 72 and 96 post-challenge. A representative section of tissue was removed from the cardiac lobe of each mouse lung for miRNA microarray analysis using the Affymetrix GeneChip miRNA Array system and a statistical limit of P¡0.01 was used to determine statistical significance of gene expression changes in lungs from animals infected with A/Texas/36/91, A/California/04/09 or A/Vietnam/1203/04. The lungs, spleen and thymus were evaluated, and microscopic findings were graded semiquantitatively. Mice infected with any of the three influenza virus strains developed bronchial and bronchiolar epithelial necrosis beginning 24 h post-infection, which was followed by reactive hypertrophy of the epithelium beginning 72 h post-infection (the lesions were not noted in control mice) (Table 1) . Specifically, intranasal infection with A/Vietnam/ 1203/04 resulted in bronchial/bronchiolar epithelial necrosis in all of the six mice beginning 24 h post-infection, and increasing in incidence and severity at 72 h. Minimal changes were observed from 72 and 96 h (Fig. 1a) . Intranasal infection of mice with A/California/04/09 resulted in bronchial/bronchiolar epithelial necrosis in five of the six mice (83 %) beginning 24 h post-infection, with similar incidence and severity at 72 and 96 h post-infection. Bronchiolar-alveolar hypertrophy was more prominent in mice infected with A/California/04/09 when compared with animals infected with A/Vietnam/1203/04, and was noted in mice 72 h post-infection and escalated in severity from 72 to 96 h post-infection (Fig. 1b) . Intranasal infection of mice with A/Texas/36/91 resulted in the mildest microscopic lesions when compared with mice challenged with A/ Vietnam/1203/04 and A/California/04/09. Bronchial/bronchiolar epithelial necrosis was evident in the majority of mice 24 h post-infection, but decreased by 72 h postinfection (Fig. 1c) . By 96 h post-infection, the necrosis was absent. Hypertrophy of bronchiolar-alveolar epithelium was evident 72 and 96 h post-infection with similar incidence and severity. Necrosis of individual lymphocytes was observed in the spleen of mice infected with A/Vietnam/ 1203/04 72 and 96 h post-infection, and in the thymus in mice infected with any of the three viruses (Fig. 1e, f, g ). Necrosis in the thymus was more severe in mice infected with A/Vietnam/1203/04 and A/California/04/09 when compared with animals infected with A/Texas/36/91. Neutrophilic infiltration of the splenic red pulp was also seen in mice infected with any of the strains (Fig. 1i, k) . Histopathological scores associated with control mice and mice used as baseline are noted in Table 2 , and control tissues are shown in Fig miRNA expression in mice infected with influenza virus expression (Li et al., 2010) , we aimed to determine whether gene expression was associated with cellular miRNA expression in the lungs from mice infected with various influenza viruses and whether the miRNA expression could act as a biomarker or signature for influenza virus infection. Fig. 4 (a-e) demonstrates the number of significantly (P¡0.01) upregulated and downregulated miRNAs, from the lungs of animals infected with the various influenza virus strains, over the 6, 12, 24, 72 and 96 h time points. These data demonstrate the overall differences in miRNA expression profile in the lung over time after the animals were infected with various influenza virus strains. Overall, these data support the pathology data; more lung pathology was observed in the animals infected with A/Vietnam/1203/04 and A/California/04/09. This may suggest a correlation between cellular miRNA expression and lung pathology.
Unique miRNA expression profiles
Next, we examined the miRNAs from the lungs of the infected animals to determine whether infection with the influenza viruses leads to a unique signature of the miRNA expression profile (Fig. 5a-f) . At 6 h, statistically significant changes in the expression of 28 miRNAs were unique to A/ Vietnam/1203/04 infection, whilst A/Texas/36/91 infection in mice led to unique changes of the expression of one miRNA (Fig. 5a ). Additionally, a change in the expression of one miRNA was shared among animals infected with A/ Vietnam/1203/04 and A/Texas/36/91. At 12 h post-challenge, statistically significant changes in the expression of 14 and six miRNAs were unique to A/Vietnam/1203/04 (Fig. 5f ), whilst changes in the expression profile of seven miRNAs were shared among all three challenged groups (Table 3) . Table 4 depicts a summary Table 2 . Incidence summary of microscopic non-neoplastic graded observations with mean severity of control mice (exposed to egg culture for 6-96 h) and baseline mice Mice were exposed to egg cultures (used to grow virus) for 6-96 h. Baseline mice were naïve. of the statistically significant (P¡0.01) unique miRNAs observed in the lung from mice infected with the different influenza virus strains at all of the time points.
Of the unique miRNAs expressed in the lungs of infected mice, seven were shared among the different groups (Table  4) (Table 4) .
When comparing the various miRNAs at the different time points, we set out to determine whether a statistical model involving various combinations of miRNAs could be used miRNA expression in mice infected with influenza virus to deduce the influenza strain that was used to infect the mice. Evaluating two or three miRNAs yielded a statistical model in which distinct miRNAs at specific time points could be used to identify the influenza virus used to infect the mice with various degrees of accuracy (Table 5) . For instance, a combination of miR-193b, miR-362-3p and mir-875-5p translated into a statistical model that could identify the influenza virus with 100 % accuracy 6 h postinfection (Table 5) . However, statistical analysis of these specific miRNAs only yielded 20, 45 and 35 % accuracy when identifying the virus when accounting for samples collected at 12, 24 and 72 h (Table 5 ). Other specific combinations of miRNAs could accurately identify the influenza virus at other time points. For example, changes in expression of miR-143, mir-339-5p and miR-708 led to a model that could accurately identify the correct influenza virus infection in mice 100 % of the time when evaluating the miRNA changes at 24 and 96 h. This same combination could identify the influenza virus correctly 70 and 80 % of the time when evaluating the 12 and 72 h time points. This statistical model describes a new method that could be used to identify the influenza virus infections in mice. Furthermore, this method may be expanded to identify and distinguish other viral infections in mice, as well as other animals and humans. However, the model is limited, at this time, to association of the proper time frame (post-challenge) with the virus that is in question and knowing the exact time that infection occurred.
DISCUSSION
Overall, this study demonstrates changes of the miRNA expression profile in the lungs harvested from mice infected with different influenza virus strains at various time points post-challenge. These data are important when evaluating the host responses to the infection of animals with various influenza virus strains and lead to a better understanding of the relationship of the differences observed in the disease progression associated with influenza virus infection in mice. This is evident when Table 3 . miRNAs shared among all virus groups Statistically significant miRNAs shared among all animals infected with all of the influenza virus strains at all time points at the P¡0.01 level. miRNAs represented with an upwards arrow were upregulated, whilst downward arrows depict miRNAs that were downregulated. 
comparing the lung pathology in mice infected with either A/Vietnam/1203/04 or A/California/04/09 with the lungs from mice infected with A/Texas/36/91. More epithelial damage and less healing response (hypertrophy) was observed in mice infected with H5N1 A/Vietnam/1203/04 and a strong healing response (hypertrophy) was noted in H1N1 A/California/04/09-infected mice at the time points in this study. H1N1 A/Texas/36/91 never caused as much damage as the other viruses, so lungs had nearly recovered at 96 h. Inflammation (fibrin and neutrophils) was a response to epithelial damage. Additionally, neutrophilic infiltration into splenic red pulp could indicate enhanced granulopoiesis or more neutrophils in circulation pooling in the sinusoids of infected animals. In some of the H5N1 A/Vietnam/1203/04-infected animals, neutrophils accumulated in the spleen in a pattern consistent with inflammation and not just simple infiltration from blood pooling.
Overall, more miRNAs were upregulated in animals infected with A/Vietnam/1203/04 or A/California/04/09. Conversely, more miRNAs were downregulated in mice infected with A/ Texas/36/91. These data suggest that miRNA upregulation in influenza-virus-infected mice may be associated with the pathology associated in the lung.
Previous studies have demonstrated an upregulation or decrease in miRNAs in lungs from mice infected with various influenza viruses (Li et al., 2010; Rogers et al., 2012; Wu et al., 2013) . A previous study has demonstrated a systematic profiling of cellular miRNAs in lung tissues harvested on days 1, 3 and 5 post-challenge from female BALB/c mice (6-7 weeks old) infected with r1918 or the non-lethal seasonal influenza virus A/Texas/36/91 (Li et al., 2010) . The authors were able to identify a group of differentiated miRNA expression patterns (Li et al., 2010) . Specifically, miR-200a and miR-223 were two miRNAs detected in lethal influenza virus infection, and may contribute to virulence of the r1918 influenza virus (Li et al., 2010) . In this current study, tissues were harvested from mice infected with various influenza virus strains in a more frequent regimen, and miR-200a was associated with (Li et al., 2010) and H5N1 virus-infected mice (Rogers et al., 2012) . Additionally, the authors of a recent report that indicates (Thitithanyanont et al., 2007) . Thus, it is logical to assert that an increase in miR-223 and miR-21 may have an effect on the production of the antiviral cytokine TNF-a and the regulation of inflammation.
The changes to the miRNA expression profiles at early time points after influenza infection could provide an insight into the viral replication mechanisms, and may offer novel early targets for antivirals and prophylaxis. When evaluating the changes of miRNA expression early after influenza virus challenge, miR-49, miR-301a and miR-141 were overexpressed by a fourfold difference when compared with baseline. The upregulation of miRNA-301a has been shown to be a potent activator of nuclear factor NF-kB signalling by upregulating NF-kB activity (Lu et al., 2011) . Cellular signalling due to NF-kB transcription is a hallmark indicator of viral infection activation as NF-kB is regarded as a regulator of immune defence to infection (Ludwig & Planz, 2008) . However, influenza viruses have been shown to possess the capability to exploit NF-kB for efficient viral replication (Ludwig & Planz, 2008) . miR-141 has also been implicated in the infection process utilized by enteroviruses and picornaviruses, and the upregulation of miR-141 has been shown to facilitate viral propagation by promoting cap-independent translation (Ho et al., 2011) . Moreover, miR-141 has been predicted as an miRNA target in H5N1 infection utilizing a bioinformatics approach (Koparde & Singh, 2010) . However, the involvement of miR-141 in the influenza virus infection cycle has yet to be determined.
Lastly, statistical analyses of specific combinations of miRNAs collected from the lung of influenza-virus-infected mice (at various time points post-challenge) led to a model that could accurately identify the influenza virus infection to various degrees. This is a novel statistical model that may be expanded to account for other viral infections in other animals, as well as humans. This is especially important when trying to identify various pathogen strains that could be associated with simultaneous outbreaks, as we have observed with influenza virus. In fact, changes in specific miRNA levels at 6 h post-infection allowed for a model that could identify the influenza strain used to infect mice with 100 % accuracy. This method may allow for identification of pathogens based on changes to various miRNAs early in the disease process. Specific changes to miRNAs at various time points may be used as a correlate of disease to accurately identify various viral strains, similar to what was observed in this study in animals infected with one of three different influenza virus types.
miRNAs have a role in the regulation of numerous genes and it has been shown that the lung has a specific miRNA expression profile. Animal studies have demonstrated that miRNAs are involved in lung homeostasis, and have a role in controlling inflammation and pathogen infections (Tomankova et al., 2010) . It is critical to evaluate and discern the role of miRNAs in viral infections. The changes in miRNA expression may be used as a biomarker to define viral diseases, in addition to a measurable parameter associated with the clinical profile or disease signature of such viral diseases. In the context of this current study, the data demonstrate differences in the miRNA profiles associated with the lung in mice infected with influenza viruses that vary in virulence and pathogenicity. As observed in a recent report, groups of strain-specific and common miRNAs are associated with infection of various influenza viruses (Wu et al., 2013) . The current study demonstrates a similar theme, which can be extrapolated to not only utilize unique and common miRNAs for the identification of pathogens after infection, but utilize these unique and common miRNA expression profiles to characterize the pathogenesis associated with different pathogen infection. In all, miRNA expression changes may be used as a biomarker associated with the clinical profile of the disease, as a tool for identifying novel targets for new therapies against viral infection and as a tool to study the association of various miRNA expression profiles with pathogenesis associated with disease.
